TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Kanisius COVID-19 vaccine drive targets 70,000 second dose recipients

Canisius College's alumni group has commenced the second phase of its free vaccination program, which started its first phase on July 5 and is due to end on Aug. 15 with an iam to fully vaccinate 70,000 recipients.

Rifki Nurfajri (The Jakarta Post)
Jakarta
Wed, August 4, 2021 Published on Aug. 4, 2021 Published on 2021-08-04T13:17:31+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Kanisius COVID-19 vaccine drive targets 70,000 second dose recipients Members of Alumni Kanisius Menteng 64 (AM64), Canisius College's alumni association, gesture during an "orientation" as part of its free vaccine program at the Jakarta Convention Center in Senayan, Central Jakarta, in this undated photograph. (Courtesy of/AM64)

A

lumni Kanisius Menteng 64 (AM64) commenced the second phase of its free COVID-19 vaccine drive at the Jakarta Convention Center on Monday, following the initial phase that ran from July 5 to 18.

The alumni association of Canisius College, a Catholic secondary school in Menteng, is targeting administering the second dose of CoronaVac, developed by China’s Sinovac, to the program’s 70,000 registered participants by Aug. 15. The majority of participants are commuters who work in Jakarta but live elsewhere.

“The second dose [...] is our commitment to the vaccine recipients. After we gave them their first shots, we must also give them their second shots,” AM64 chairman Irlam Suud said in a statement.

AM64 is collaborating with the Jakarta administration, private companies PT Combiphar, PT Petrosea and PT Prosehat, as well as nonprofit organization Eka Tjipta Foundation and a state-owned company, to deliver its free vaccine program.

Read also: Kanisius alumni group launches free vaccine drive, targets 140,000 doses by August

Following AM64, which also ran a separate vaccine program for the elderly in March-April, other alumni associations have started their own programs to pick up the slack in public vaccination drives. In Jakarta, for example, just 2.8 million residents are fully vaccinated, or 32.5 percent of the targeted population.

Ikatan Alumni ITB (IA-ITB), the alumni association of the Bandung Institute of Technology, also rolled out a free vaccination program for Jakarta residents. According to the group’s Instagram account (@iaitb_official), it administered the CoronaVac vaccine to 300 people each day from July 29 to 31.

Separately, Ikatan Alumni Universitas Indonesia (Iluni UI), the University of Indonesia alumni network, is holding a free vaccine program in Jakarta from July 22 to Sept. 15 for 50,000 recipients above 12 years old.

Iluni UI is also administering Sinovac’s CoronaVac vaccine, which underwent clinical trials in collaboration with state-owned pharmaceutical PT Bio Farma in Bandung, West Java, and comprises the bulk of Indonesia’s vaccine supply.

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.